Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Ovarian Neoplasms

  Free Subscription

Articles published in Histopathology

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    May 2016
  1. BAKHSH S, Kinloch M, Hoang LN, Soslow RA, et al
    Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
    Histopathology. 2016;68:916-24.
    PubMed     Text format     Abstract available

  2. HIROSE T, Nobusawa S, Kusanishi H
    Ovarian primitive-type neuroectodermal tumour composed of desmoplastic/nodular medulloblastoma-like and atypical teratoid/rhabdoid tumour components.
    Histopathology. 2016;68:939-42.
    PubMed     Text format    

    March 2016
  3. BEIRNE JP, McArt DG, James JA, Salto-Tellez M, et al
    p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma.
    Histopathology. 2016;68:615-8.
    PubMed     Text format    

  4. TAYLOR J, Clarke BA, Hasan NU, Gasljevic G, et al
    Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non-neoplastic remnants?
    Histopathology. 2016;68:596-602.
    PubMed     Text format     Abstract available

  5. KATO N, Kurotaki H, Uchigasaki S, Fukase M, et al
    Ovarian clear cell carcinoma with plasma cell-rich inflammatory stroma: a clear cell carcinoma subgroup with distinct clinicopathological features.
    Histopathology. 2016;68:588-95.
    PubMed     Text format     Abstract available

    May 2015
  6. BENNETT JA, Dong F, Young RH, Oliva E, et al
    Clear cell carcinoma of the ovary: evaluation of prognostic parameters based on a clinicopathological analysis of 100 cases.
    Histopathology. 2015;66:808-15.
    PubMed     Text format     Abstract available

  7. AITKEN SJ, Presneau N, Khatri B, Flanagan AM, et al
    Mutations in IDH1 and IDH2 are not present in sporadic ovarian sex cord-stromal tumours.
    Histopathology. 2015;66:897-8.
    PubMed     Text format    

    March 2015
  8. MCCLUGGAGE WG, Stewart CJ, Iacobelli J, Soma A, et al
    Microscopic extraovarian sex cord proliferations: an undescribed phenomenon.
    Histopathology. 2015;66:555-64.
    PubMed     Text format     Abstract available

  9. WANG J, El-Bahrawy M
    Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
    Histopathology. 2015;66:529-35.
    PubMed     Text format     Abstract available

  10. HUANG HN, Lin MC, Tseng LH, Chiang YC, et al
    Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Histopathology. 2015;66:517-28.
    PubMed     Text format     Abstract available

    August 2014
  11. SINGH N, Gilks CB, Wilkinson N, McCluggage WG, et al
    Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.
    Histopathology. 2014;65:149-54.
    PubMed     Text format     Abstract available

    May 2014
  12. ERVINE A, Leung S, Gilks CB, McCluggage WG, et al
    Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
    Histopathology. 2014;64:840-6.
    PubMed     Text format     Abstract available

    April 2014
  13. HIGGINS PA, Brady A, Dobbs SP, Salto-Tellez M, et al
    Epidermal growth factor receptor (EGFR), HER2 and insulin-like growth factor-1 receptor (IGF-1R) status in ovarian adult granulosa cell tumours.
    Histopathology. 2014;64:633-8.
    PubMed     Text format     Abstract available

  14. SINGH N, Gilks CB, Huntsman DG, Smith JH, et al
    Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status.
    Histopathology. 2014;64:626-32.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.